Terkko Navigator / Isola, J.

17α-Estradiol promotes ovarian aging in growth hormone receptor knockout mice, but not wild-type littermates.

Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.

Cytokeratin-supervised deep learning for automatic recognition of epithelial cells in breast cancers stained for ER, PR, and Ki-67.

A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast And Gastric Cancers Resistant to Trastuzumab Emtansine.

Breast cancer outcome prediction with tumour tissue images and machine learning.

Intrafollicular Paraoxonase 1 activity and the steroidogenic potential of the first postpartum dominant follicle in Dairy Cows.

L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.

Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.

Fluoro-Chromogenic Labelling for Detection of MCM2 to Assess Proliferation Activity in HER2-amplified Breast Carcinomas.

Optimized JPEG 2000 Compression for Efficient Storage of Histopathological Whole-Slide Images.

Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation.

Quantifying shorebird habitat in managed wetlands by modeling shallow water depth dynamics.

Digital image analysis of the tissue surface areas of site-designated and bilaterally pooled prostate biopsies.

Correlation of quantitative total HER2 expression and HER2 homodimers with histopathologic characteristics of breast cancers in the FinHer study.

A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancer.

Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry.

L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.

Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer.

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.

Assessment of PARP protein expression in epithelial ovarian cancer by ELISA pharmacodynamic assay and immunohistochemistry.

Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.

[Clinical pathology on the verge of virtual microscopy].

Quantification of Estrogen Receptor-Alpha Expression in Human Breast Carcinomas With a Miniaturized, Low-Cost Digital Microscope: A Comparison with a High-End Whole Slide-Scanner.

Free digital image analysis software helps to resolve equivocal scores in HER2 immunohistochemistry.

Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology.

Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.

Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies.

Elevated Levels of StAR-Related Lipid Transfer Protein 3 Alter Cholesterol Balance and Adhesiveness of Breast Cancer Cells: Potential Mechanisms Contributing to Progression of HER2-Positive Breast Cancers.

Trastuzumab emtansine: mechanisms of action and drug resistance.

Quantitative Analysis ofγ-H2AX and p53 Nuclear Expression Levels in Ovarian and Fallopian Tube Epithelium from Risk-reducing Salpingo-Oophorectomies in BRCA1 and BRCA2 Mutation Carriers.

Endoglin, VEGF, and its receptors in predicting metastases in endometrial carcinoma.

The expression patterns of gremlin 1 and noggin in normal adult and tumor tissues.

Preservation of nucleic acids and tissue morphology in paraffin-embedded clinical samples: comparison of five molecular fixatives.

Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.

Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices.

Chemical Castration and Antiandrogens Induce Differential Gene Expression in Prostate Cancer.

ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.

Long-term prognosis of breast cancer detected by mammography screening or other methods.

Characterization of Non-Specific Cytotoxic Cell Receptor Protein 1: A New Member of the Lectin-Type Subfamily of F-Box Proteins.

Overall and worst Gleason scores are equally good predictors of prostate cancer progression.

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.

Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein.

Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.

Trastuzumab-DM1 causes tumor growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo.

Routine dual-color immunostaining with a 3-antibody cocktail improves the detection of small cancers in prostate needle biopsies.

Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer.

[Targeted cytotoxic drugs emerging for cancer therapy].